Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT05720806
Other study ID # STUDY22080053
Secondary ID
Status Enrolling by invitation
Phase N/A
First received
Last updated
Start date May 1, 2023
Est. completion date July 28, 2025

Study information

Verified date April 2024
Source University of Pittsburgh
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study is being proposed to examine weight bearing precautions following hip arthroscopic labral repair, femoroplasty, and capsular closure. Standard post operative protocols limit weight bearing for 2-6 weeks depending on individual surgeons. Cadaveric studies demonstrate that minimal force during weight bearing is distributed through labrum. Therefore, progressing weight bearing earlier in these patients post operatively may help progress faster and improve outcomes. Data collected will include demographic information, radiological data, operative procedures and PRO data.


Description:

The study will be conducted at UPMC St. Margaret's Hip Preservation Program. Consented patients who undergo acetabular labral repair and femoroplasty will be included in randomization of weight-bearing status. Two separate protocols will be created to indicate weight bearing status, either WBAT immediately post-op or FFWB immediately post-op, to distribute to rehabilitation staff to ensure compliance. Immediately after the surgical procedure, the surgeon will be blinded and a randomized pamphlet with post-operative instructions with weight bearing education will be given to PACU nursing staff to educate patients and fit crutches.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 80
Est. completion date July 28, 2025
Est. primary completion date January 1, 2025
Accepts healthy volunteers No
Gender All
Age group 12 Years to 65 Years
Eligibility Inclusion Criteria: - Age>= 12 years - Diagnoses: femoroacetabular impingement and hip labral tears. - Surgical procedures performed: Hip arthroscopy with femoroplasty and labral repair. - Surgery completed at UPMC Children's or UPMC St. Margaret's Hospital - unilateral and bilateral hip patients Exclusion Criteria: - MSK tumor-related FAI or dysplasia - generalized hypermobility - revision surgeries

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Weight Bearing as tolerated (WBAT) immediately following surgery.
Subject will be provided standard of care physical therapy following surgical intervention, except will be able to self-select weight bearing based on pain and confidence.
Flat foot weight bearing (FFWB) immediately following surgery
Subject will be provided standard of care physcial therapy following surgical intervention except

Locations

Country Name City State
United States UPMC Hip Preservation Program Pittsburgh Pennsylvania

Sponsors (1)

Lead Sponsor Collaborator
University of Pittsburgh

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary International Hip Outcome Tool 12 (iHot-12) Scoring ranges from 0-100
each question is rated from 0-100 and final score is the mean of all questions answered by subject
higher scoring indicating higher quality of life due to hip function
up to 6 months post-operative
Primary Hip and Groin Outcome Score (HAGOS) This outcome includes 6 subscales, these are scored independently, and no aggregate scoring is calculated as each section assesses different dimensions separately.
Subscales (raw scores for each subscale converted to a 0-100 scale with higher score indicating higher level of function):
Pain
Symptoms
Activities of Daily Life
Function in Sport and recreation
Participation in Physical Activities
hip and groin-related quality of life
up to 6 months post-operative
Primary Hip Outcome Score (HOS) ADL Outcome assessing function with activities of daily living. Higher score is given for higher level of function and lower score indicating reduced function.
0-68 aggregate scoring converted to 0-100 scale.
up to 6 months post-operative
Primary Hip Outcome Score (HOS) Sport Outcome assessing function/difficulty completing dynamic activities associated with sports participation. Higher score is given for higher level of function and lower score indicating reduced function.
0-36 aggregate scoring converted to 0-100 scale.
up to 6 months post-operative
Primary Tampa Scale for Kinesiophobia-11 Outcome measure assessing fear of pain with movement. Scores range from 11 to 44. Higher scores indicate greater fear of movement up to 6 months post-operative
Secondary Isometric strength measures hip add, abd, ER, and extension Strength measures will be taken isometrically at post-operative follow ups. 6-week, 3 months, and 6-month post-operative
Secondary Diagnostic ultrasound assessment of bilateral anterior hip capsule thickness Physician while blinded will perform ultrasound evaluation of the hip capsule to ensure healing.
Ultrasound will measure the following:
1.Assess the bilateral hip anterior capsule in all patients, assessing for internal consistency or changes in capsular thickness from side to side. Normal hip capsular thickness has been reported as 7-8 mm, dysplastic hips range 3.2 +/- 0.5 mm, and femoroacetabular impingement subjects 4.7 +/- 0.6 mm.
3 months post-operative
Secondary Diagnostic ultrasound assessment of incision widening Physician while blinded will perform ultrasound evaluation of the hip capsule to ensure healing.
1. Evaluation of capsular incision widening, cyst, attenuation and thinning from established norms. Normal hip capsular thickness has been reported as 7-8 mm, dysplastic hips range 3.2 +/- 0.5 mm, and femoroacetabular impingement subjects 4.7 +/- 0.6 mm
3 months post-operative
Secondary Diagnostic ultrasound for focal echogenic adhesions Physician while blinded will perform ultrasound evaluation of the hip capsule to ensure healing.
1. Evaluate for focal echogenic adhesions or dyskinetic motion between capsule and overlying iliopsoas complex with activation of hip flexion.
3 months post-operative
See also
  Status Clinical Trial Phase
Recruiting NCT05893823 - Retrospective Study on Radiological Factors Predictive of Psoas Impingement
Completed NCT05310240 - Analysis of the Relevance of Radiologic Parameters on the Outcome After Hip Arthroscopy
Withdrawn NCT05710146 - Tranexamic Acid (TXA) in Hip Arthroscopy Phase 3
Terminated NCT04212650 - Losartan to Improve Hip Microfracture Phase 1/Phase 2